| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.34 | 0.07 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.27 | 0.07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.09 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |